Major G N, Gardner E J, Carne A F, Lawley P D
Alkylation Carcinogenesis Team, Institute of Cancer Research, Chester Beatty Laboratories, London, UK.
Nucleic Acids Res. 1990 Mar 25;18(6):1351-9. doi: 10.1093/nar/18.6.1351.
DNA repair by O6-methylguanine-DNA methyltransferase (O6-MT) is accomplished by removal by the enzyme of the methyl group from premutagenic O6-methylguanine-DNA, thereby restoring native guanine in DNA. The methyl group is transferred to an acceptor site cysteine thiol group in the enzyme, which causes the irreversible inactivation of O6-MT. We detected a variety of different forms of the methylated, inactivated enzyme in crude extracts of human spleen of molecular weights higher and lower than the usually observed 21-24kDa for the human O6-MT. Several apparent fragments of the methylated form of the protein were purified to homogeneity following reaction of partially-purified extract enzyme with O6-[3H-CH3]methylguanine-DNA substrate. One of these fragments yielded amino acid sequence information spanning fifteen residues, which was identified as probably belonging to human methyltransferase by virtue of both its significant sequence homology to three procaryote forms of O6-MT encoded by the ada, ogt (both from E. coli) and dat (B. subtilis) genes, and sequence position of the radiolabelled methyl group which matched the position of the conserved procaryote methyl acceptor site cysteine residue. Statistical prediction of secondary structure indicated good homologies between the human fragment and corresponding regions of the constitutive form of O6-MT in procaryotes (ogt and dat gene products), but not with the inducible ada protein, indicating the possibility that we had obtained partial amino acid sequence for a non-inducible form of the human enzyme. The identity of the fragment sequence as belonging to human methyltransferase was more recently confirmed by comparison with cDNA-derived amino acid sequence from the cloned human O6-MT gene from HeLa cells (1). The two sequences compared well, with only three out of fifteen amino acids being different (and two of them by only one nucleotide in each codon).
O6-甲基鸟嘌呤-DNA甲基转移酶(O6-MT)进行的DNA修复是通过该酶从致突变的O6-甲基鸟嘌呤-DNA上去除甲基来实现的,从而使DNA中的鸟嘌呤恢复为天然状态。甲基被转移到该酶的一个受体位点半胱氨酸硫醇基团上,这会导致O6-MT不可逆地失活。我们在人脾脏粗提物中检测到了多种不同形式的甲基化失活酶,其分子量高于和低于通常观察到的人O6-MT的21 - 24kDa。在部分纯化的提取物酶与O6-[3H-CH3]甲基鸟嘌呤-DNA底物反应后,该蛋白甲基化形式的几个明显片段被纯化至同质。其中一个片段产生了跨越15个残基的氨基酸序列信息,由于其与由ada、ogt(均来自大肠杆菌)和dat(枯草芽孢杆菌)基因编码的三种原核生物形式的O6-MT具有显著的序列同源性,以及放射性标记甲基的序列位置与保守的原核生物甲基受体位点半胱氨酸残基的位置相匹配,因此被确定可能属于人甲基转移酶。二级结构的统计预测表明,人片段与原核生物中O6-MT组成形式的相应区域(ogt和dat基因产物)之间具有良好的同源性,但与可诱导的ada蛋白没有同源性,这表明我们可能获得了人酶的一种非诱导形式的部分氨基酸序列。最近,通过与来自HeLa细胞的克隆人O6-MT基因的cDNA衍生氨基酸序列进行比较,进一步证实了该片段序列属于人甲基转移酶(1)。两者序列匹配良好,15个氨基酸中只有3个不同(其中两个在每个密码子中仅相差一个核苷酸)。